Skip to main content
SpringerLink
Log in

The no-reflow phenomenon associated with percutaneous coronary intervention: its mechanisms and treatment

  • Review Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

In patients with acute coronary syndrome (ACS), the immediate therapeutic goal is to establish patency of the infarct-related artery and to achieve optimal myocardial tissue reperfusion. Coronary microvasculatures, however, are often damaged irreversibly due to myocardial ischemia and reperfusion, and flow to the previously ischemic myocardium is markedly reduced, a phenomenon known as the “no-reflow phenomenon”. In clinical settings, percutaneous coronary intervention (PCI) may accelerate embolization of plaque gruels and microthrombi to the microvessels, which further reduces tissue perfusion. The microvascular dysfunction attenuates the beneficial impact of PCI. The extent of the no-reflow phenomenon correlates with infarct size, and it has additional prognostic information. Patients with the no-reflow phenomenon have poor functional and clinical outcomes. Recent advances in imaging modalities have enabled diagnosis of the no-reflow phenomenon and assessment of the mechanisms of the microvascular dysfunction in patients. Use of pharmacological interventions and catheter-based devices to retrieve embolic materials have been proposed, and some of them are associated with improvement in clinical outcomes. Thus, we should keep in mind that only the achievement of successful myocardial perfusion is associated with better functional and clinical outcomes in patients with ACS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699–705.

    CAS  PubMed  Google Scholar 

  2. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part I. Evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004;109:310–5.

    Article  PubMed  Google Scholar 

  3. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3:499–506.

    Article  PubMed  Google Scholar 

  4. Kloner RA, Jennings RB. The ‘no reflow’ phenomenon after temporary occlusion in the dog. J Clin Invest. 1974;54:1491–508.

    Article  Google Scholar 

  5. Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation. 2005;112:906–15.

    Article  CAS  PubMed  Google Scholar 

  6. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van ’t Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23:1112–7.

    Article  CAS  PubMed  Google Scholar 

  7. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945–52.

    CAS  PubMed  Google Scholar 

  8. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846–61.

    CAS  PubMed  Google Scholar 

  9. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–51.

    Article  CAS  PubMed  Google Scholar 

  10. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991;17:621–6.

    Article  CAS  PubMed  Google Scholar 

  11. Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985;109:1225–31.

    Article  CAS  PubMed  Google Scholar 

  12. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570–80.

    CAS  PubMed  Google Scholar 

  13. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002;105:2148–52.

    Article  PubMed  Google Scholar 

  14. Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation. 2004;109:1735–40.

    Article  PubMed  Google Scholar 

  15. Quan VH, Huynh R, Seifert PA, Kuchela A, Chen WH, Sutsch G, et al. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Am J Cardiol. 2005;95:1415–9.

    Article  PubMed  Google Scholar 

  16. Bailey SR. Drug-eluting stents have made brachytherapy obsolete. Curr Opin Cardiol. 2004;19:598–600.

    Article  PubMed  Google Scholar 

  17. Yamamoto K, Ito H, Iwakura K, Kawano S, Ikushima M, Masuyama T, et al. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction grade 2 in acute myocardial infarction. J Am Coll Cardiol. 2002;40:1755–60.

    Article  PubMed  Google Scholar 

  18. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implication in determining extent of myocardial salvage. Circulation. 1993;88:596–606.

    CAS  PubMed  Google Scholar 

  19. Yano A, Ito H, Iwakura K, Kimura R, Tanaka K, Okamura A, et al. Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol. 2004;43:1799–806.

    Article  PubMed  Google Scholar 

  20. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;9:1993–9.

    Google Scholar 

  21. Akasaka T, Yoshida K, Kawamoto T, Kaji S, Ueda Y, Yamamuro A, et al. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation. 2000;101:2361–7.

    CAS  PubMed  Google Scholar 

  22. Cannon CP. Importance of TIMI 3 flow. Circulation. 2001;104:624–6.

    CAS  PubMed  Google Scholar 

  23. Iwakura K, Ito H, Takiuchi S, Taniyama Y, Nakatsuchi Y, Negoro S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94:1269–75.

    CAS  PubMed  Google Scholar 

  24. Iwakura K, Ito H, Kawano S, Okamura A, Tanaka k, Nishida Y, et al. Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J. 2004;25:1526–33.

    Article  CAS  PubMed  Google Scholar 

  25. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–30.

    CAS  PubMed  Google Scholar 

  26. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–72.

    CAS  PubMed  Google Scholar 

  27. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol. 1999;34:1932–8.

    Article  CAS  PubMed  Google Scholar 

  28. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the “no reflow” phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223–8.

    CAS  PubMed  Google Scholar 

  29. Dwivedi G, Janardhanan R, Hayat SA, Swinburn JM, Senior R. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol. 2007;50:327–34.

    Article  PubMed  Google Scholar 

  30. Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, Torre GL, on behalf of the AMICI Investigators, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. Results of the multicenter AMICI study. J Am Coll Cardiol. 2008;51:552–9.

    Article  PubMed  Google Scholar 

  31. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J. 2008;29:3002–10.

    Article  PubMed  Google Scholar 

  32. Mongeon FP, Bélisle P, Joseph L, Eisenberg MJ, Rinfret S. Adjunctive thrombectomy for acute myocardial infarction: a Bayesian meta-analysis. Circ Cardiovasc Interv. 2010;3:6–16.

    Article  PubMed  Google Scholar 

  33. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29:2989–3001.

    Article  PubMed  Google Scholar 

  34. Nakamura T, Kubo N, Seki Y, Ikeda N, Ishida T, Funayama H, et al. Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction. Circ J. 2004;68:763–8.

    Article  PubMed  Google Scholar 

  35. Li SS, Lam CW, So YC, Wong CH, Yiu SF, Ho D, et al. The use of a distal occlusion balloon protection device in acute coronary syndrome. Int J Cardiol. 2003;92:281–4.

    Article  PubMed  Google Scholar 

  36. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol. 2003;92:1331–5.

    Article  PubMed  Google Scholar 

  37. Huang Z, Katoh O, Nakamura S, Negoro S, Kobayashi T, Tanigawa J. Evaluation of the PercuSurge Guardwire Plus Temporary Occlusion and Aspiration System during primary angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv. 2003;60:443–51.

    Article  PubMed  Google Scholar 

  38. Orrego PS, Delgado A, Piccalo G, Salvadè P, Bonacina E, Klugmann S. Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: single-center experience. Catheter Cardiovasc Interv. 2003;60:152–8.

    Article  PubMed  Google Scholar 

  39. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063–72.

    Article  CAS  PubMed  Google Scholar 

  40. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation. 2005;112:1462–9.

    Article  PubMed  Google Scholar 

  41. Okamura A, Ito H, Iwakura K, Kawano S, Inoue K, Maekawa Y, et al. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction. Efficacy of distal protection device. J Am Coll Cardiol. 2005;45:212–5.

    Article  PubMed  Google Scholar 

  42. Okamura A, Ito H, Iwakura K, Kurotobi T, Koyama Y, Date M, et al. Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: quantitative study with Doppler guidewire. J Am Coll Cardiol Cardiovasc Interv. 2008;1:268–76.

    Google Scholar 

  43. Mizote I, Ueda Y, Ohtani T, Shimizu M, Takeda Y, Oka T, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation. 2005;112:1001–7.

    Article  PubMed  Google Scholar 

  44. Ovize M, Baxter GF, Lisa FD, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. doi:10.1093/cvr/cvq129.

  45. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, et al. Postconditioning the human heart. Circulation. 2005;112:2143–8.

    Article  PubMed  Google Scholar 

  46. Lønborg PJ, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv. 2010;3:34–41.

    Article  PubMed  Google Scholar 

  47. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895–903.

    Article  CAS  PubMed  Google Scholar 

  48. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–4.

    Article  CAS  PubMed  Google Scholar 

  49. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154–9.

    CAS  PubMed  Google Scholar 

  50. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45:1775–80.

    Article  CAS  PubMed  Google Scholar 

  51. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36.

    CAS  PubMed  Google Scholar 

  52. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990;82:609–19.

    CAS  PubMed  Google Scholar 

  53. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654–66.

    Article  CAS  PubMed  Google Scholar 

  54. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005;112:1284–8.

    Article  CAS  PubMed  Google Scholar 

  55. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997;30:1193–9.

    Article  CAS  PubMed  Google Scholar 

  56. Pasceri V, Pristipino C, Pelliccia F, Granatelli A, Speciale G, Roncella A, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol. 2005;95:1358–61.

    Article  CAS  PubMed  Google Scholar 

  57. Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Circulation. 2000;102:3032–8.

    PubMed  Google Scholar 

  58. Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001;38:1644–50.

    Article  CAS  PubMed  Google Scholar 

  59. Botker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375:727–34.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, 2-5-1 Kita-ku, Shikata-cho, Okayama, 700-8558, Japan

    Hiroshi Ito

Authors
  1. Hiroshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Ito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, H. The no-reflow phenomenon associated with percutaneous coronary intervention: its mechanisms and treatment. Cardiovasc Interv and Ther 26, 2–11 (2011). https://doi.org/10.1007/s12928-010-0034-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-010-0034-z

Keywords

Search

Navigation